Skip to content

The Value of Using Mini-oral Pulse Steroid Therapy Along With Non Cultured Epidermal Cell Suspension (NCES) in Stable Resistant Vitiligo

The Value of Using Mini-oral Pulse Steroid Therapy Along With Non Cultured Epidermal Cell Suspension in Stable Resistant Vitiligo: An Interventional Prospective Controlled Trial.

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06974669
Acronym
NCES
Enrollment
40
Registered
2025-05-16
Start date
2025-05-12
Completion date
2025-10-01
Last updated
2025-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo

Keywords

vitiligo, surgery, mini-oral pulse steroid therapy, resistant

Brief summary

Assessing the additive value of mini-oral pulse steroid therapy in surgical treatment of acral and difficult to treat sites of vitiligo

Interventions

this study is the first according to the best of our knowledge assessing the value of adding mini oral pulse steroid therapy to non cultured epidermal suspension in treatment of stable acral and difficult to treat vitiligo

this is the best surgical technique for surgical treatment of vitiligo that would be done for both arms

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with non-segmental vitiligo (NSV) with acral or resistant lesions over the elbows and knees, that has not responded to conventional treatment * Stability for ≥ 1 year * Age ≥18 years * Lack of topical treatment for at least 1 month prior to surgery and systemic treatment for at least 3 months prior to surgery.

Exclusion criteria

* Non acral NSV responsive to conventional treatment modalities * Active vitiligo; new lesions, expansion of old lesions, confetti like lesions, ill-defined edges or koebnerization in \< 1 year * Age \< 18 years. * Pregnant females. * Patients with hypertension, diabetes or tuberculosis * Topical treatment in the past month and systemic treatment in the past 3 months.

Design outcomes

Primary

MeasureTime frameDescription
comparing percent change in pigmentation in both arms3 months• Comparing percent change of pigmentation as per VESTA score after 3 months of treatment with NCES with and without mini oral pulse steroids.
comparing percent change in surface area in both arms3 months• Comparing percent change in the surface area of the depigmented patch following NCES using point counting technique.

Secondary

MeasureTime frameDescription
comparing physician global assessment in both arms3 months• Comparing physician global assessment after treatment with NCES with and without oral mini-pulse therapy

Countries

Egypt

Contacts

Primary ContactDr. Mogawer, MD, PhD
raniamogawer@kasralainy.edu.eg+20106815330
Backup ContactProf. Nanis Ragab, MD, PhD
nanisragab@kasralainy.edu.eg+201227449161

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026